118 related articles for article (PubMed ID: 33740522)
1. Parecoxib improves atherosclerotic plaque stability by suppressing inflammation and inhibiting matrix metalloproteinases production.
Gong C; Qi Y; Xu Y; Tang X; Liang F; Chen L
Biomed Pharmacother; 2021 Jun; 138():111423. PubMed ID: 33740522
[TBL] [Abstract][Full Text] [Related]
2. Green tea polyphenol epigallocatechin-3-gallate increases atherosclerotic plaque stability in apolipoprotein E-deficient mice fed a high-fat diet.
Wang Q; Zhang J; Li Y; Shi H; Wang H; Chen B; Wang F; Wang Z; Yang Z; Wang L
Kardiol Pol; 2018; 76(8):1263-1270. PubMed ID: 29862488
[TBL] [Abstract][Full Text] [Related]
3. The antioxidant N-acetylcysteine promotes atherosclerotic plaque stabilization through suppression of RAGE, MMPs and NF-κB in ApoE-deficient mice.
Lu Y; Qin W; Shen T; Dou L; Man Y; Wang S; Xiao C; Li J
J Atheroscler Thromb; 2011; 18(11):998-1008. PubMed ID: 21873804
[TBL] [Abstract][Full Text] [Related]
4. [Effects of astragali radix extract on matrix metalloproteinase 9 expression and atherosclerotic plaque formation in aorta of apolipoprotein E deficient mice fed with high fat diet].
You Y; Duan Y; Zhang XL; Kang J; Yan CH; Zhang XL; Feng JT; Han YL
Zhonghua Xin Xue Guan Bing Za Zhi; 2012 Jun; 40(6):522-6. PubMed ID: 22943650
[TBL] [Abstract][Full Text] [Related]
5. Crocus sativus L. aqueous extract reduces atherogenesis, increases atherosclerotic plaque stability and improves glucose control in diabetic atherosclerotic animals.
Christodoulou E; Kadoglou NPE; Stasinopoulou M; Konstandi OA; Kenoutis C; Kakazanis ZI; Rizakou A; Kostomitsopoulos N; Valsami G
Atherosclerosis; 2018 Jan; 268():207-214. PubMed ID: 29128090
[TBL] [Abstract][Full Text] [Related]
6. Rivaroxaban, a novel oral anticoagulant, attenuates atherosclerotic plaque progression and destabilization in ApoE-deficient mice.
Hara T; Fukuda D; Tanaka K; Higashikuni Y; Hirata Y; Nishimoto S; Yagi S; Yamada H; Soeki T; Wakatsuki T; Shimabukuro M; Sata M
Atherosclerosis; 2015 Oct; 242(2):639-46. PubMed ID: 25817329
[TBL] [Abstract][Full Text] [Related]
7. Protease-Activated Receptor-2 Plays a Critical Role in Vascular Inflammation and Atherosclerosis in Apolipoprotein E-Deficient Mice.
Hara T; Phuong PT; Fukuda D; Yamaguchi K; Murata C; Nishimoto S; Yagi S; Kusunose K; Yamada H; Soeki T; Wakatsuki T; Imoto I; Shimabukuro M; Sata M
Circulation; 2018 Oct; 138(16):1706-1719. PubMed ID: 29700120
[TBL] [Abstract][Full Text] [Related]
8. Doxycycline stabilizes vulnerable plaque via inhibiting matrix metalloproteinases and attenuating inflammation in rabbits.
Dong M; Zhong L; Chen WQ; Ji XP; Zhang M; Zhao YX; Li L; Yao GH; Zhang PF; Zhang C; Zhang L; Zhang Y
PLoS One; 2012; 7(6):e39695. PubMed ID: 22737253
[TBL] [Abstract][Full Text] [Related]
9. Pioglitazone-Incorporated Nanoparticles Prevent Plaque Destabilization and Rupture by Regulating Monocyte/Macrophage Differentiation in ApoE-/- Mice.
Nakashiro S; Matoba T; Umezu R; Koga J; Tokutome M; Katsuki S; Nakano K; Sunagawa K; Egashira K
Arterioscler Thromb Vasc Biol; 2016 Mar; 36(3):491-500. PubMed ID: 26821947
[TBL] [Abstract][Full Text] [Related]
10. Multidimensional Contribution of Matrix Metalloproteinases to Atherosclerotic Plaque Vulnerability: Multiple Mechanisms of Inhibition to Promote Stability.
Ruddy JM; Ikonomidis JS; Jones JA
J Vasc Res; 2016; 53(1-2):1-16. PubMed ID: 27327039
[TBL] [Abstract][Full Text] [Related]
11. Targeting Coagulation Factor Xa Promotes Regression of Advanced Atherosclerosis in Apolipoprotein-E Deficient Mice.
Posthuma JJ; Posma JJN; van Oerle R; Leenders P; van Gorp RH; Jaminon AMG; Mackman N; Heitmeier S; Schurgers LJ; Ten Cate H; Spronk HMH
Sci Rep; 2019 Mar; 9(1):3909. PubMed ID: 30846818
[TBL] [Abstract][Full Text] [Related]
12. Parecoxib reduced ventilation induced lung injury in acute respiratory distress syndrome.
Meng FY; Gao W; Ju YN
BMC Pharmacol Toxicol; 2017 Mar; 18(1):25. PubMed ID: 28356130
[TBL] [Abstract][Full Text] [Related]
13. Gene expression levels of matrix metalloproteinases in human atherosclerotic plaques and evaluation of radiolabeled inhibitors as imaging agents for plaque vulnerability.
Müller A; Krämer SD; Meletta R; Beck K; Selivanova SV; Rancic Z; Kaufmann PA; Vos B; Meding J; Stellfeld T; Heinrich TK; Bauser M; Hütter J; Dinkelborg LM; Schibli R; Ametamey SM
Nucl Med Biol; 2014 Aug; 41(7):562-9. PubMed ID: 24853402
[TBL] [Abstract][Full Text] [Related]
14. Insulin-Like Growth Factor-1 Receptor Deficiency in Macrophages Accelerates Atherosclerosis and Induces an Unstable Plaque Phenotype in Apolipoprotein E-Deficient Mice.
Higashi Y; Sukhanov S; Shai SY; Danchuk S; Tang R; Snarski P; Li Z; Lobelle-Rich P; Wang M; Wang D; Yu H; Korthuis R; Delafontaine P
Circulation; 2016 Jun; 133(23):2263-78. PubMed ID: 27154724
[TBL] [Abstract][Full Text] [Related]
15. Protective effect of simvastatin on arterial plaque instability induced by p-cresyl sulfate.
Li HY; Liu F; Gao C; Wang HR
Eur Rev Med Pharmacol Sci; 2018 Sep; 22(18):6149-6155. PubMed ID: 30280803
[TBL] [Abstract][Full Text] [Related]
16. Combination of tanshinone IIA and astragaloside IV attenuate atherosclerotic plaque vulnerability in ApoE(-/-) mice by activating PI3K/AKT signaling and suppressing TRL4/NF-κB signaling.
Wang N; Zhang X; Ma Z; Niu J; Ma S; Wenjie W; Chen J
Biomed Pharmacother; 2020 Mar; 123():109729. PubMed ID: 31887543
[TBL] [Abstract][Full Text] [Related]
17. Endothelial Cell-Specific Deletion of P2Y2 Receptor Promotes Plaque Stability in Atherosclerosis-Susceptible ApoE-Null Mice.
Chen X; Qian S; Hoggatt A; Tang H; Hacker TA; Obukhov AG; Herring PB; Seye CI
Arterioscler Thromb Vasc Biol; 2017 Jan; 37(1):75-83. PubMed ID: 27856454
[TBL] [Abstract][Full Text] [Related]
18. Myeloid A disintegrin and metalloproteinase domain 10 deficiency modulates atherosclerotic plaque composition by shifting the balance from inflammation toward fibrosis.
van der Vorst EP; Jeurissen M; Wolfs IM; Keijbeck A; Theodorou K; Wijnands E; Schurgers L; Weber S; Gijbels MJ; Hamers AA; Dreymueller D; Rose-John S; de Winther MP; Ludwig A; Saftig P; Biessen EA; Donners MM
Am J Pathol; 2015 Apr; 185(4):1145-55. PubMed ID: 25659879
[TBL] [Abstract][Full Text] [Related]
19. Inhibiting Integrin α5 Cytoplasmic Domain Signaling Reduces Atherosclerosis and Promotes Arteriogenesis.
Budatha M; Zhang J; Zhuang ZW; Yun S; Dahlman JE; Anderson DG; Schwartz MA
J Am Heart Assoc; 2018 Jan; 7(3):. PubMed ID: 29382667
[TBL] [Abstract][Full Text] [Related]
20. Acute perioperative-stress-induced increase of atherosclerotic plaque volume and vulnerability to rupture in apolipoprotein-E-deficient mice is amenable to statin treatment and IL-6 inhibition.
Janssen H; Wagner CS; Demmer P; Callies S; Sölter G; Loghmani-khouzani H; Hu N; Schuett H; Tietge UJ; Warnecke G; Larmann J; Theilmeier G
Dis Model Mech; 2015 Sep; 8(9):1071-80. PubMed ID: 26092124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
